Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Iradimed (IRMD) Leases (2019 - 2025)

Iradimed (IRMD) has disclosed Leases for 7 consecutive years, with $59221.0 as the latest value for Q1 2025.

  • On a quarterly basis, Leases fell 96.94% to $59221.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $59221.0, a 96.94% decrease, with the full-year FY2024 number at $154688.0, down 92.43% from a year prior.
  • Leases was $59221.0 for Q1 2025 at Iradimed, down from $154688.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $2.7 million in Q1 2021 to a low of $59221.0 in Q1 2025.
  • A 5-year average of $1.8 million and a median of $2.2 million in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: fell 2.76% in 2023, then tumbled 96.94% in 2025.
  • Iradimed's Leases stood at $2.5 million in 2021, then dropped by 11.15% to $2.2 million in 2022, then fell by 7.36% to $2.0 million in 2023, then tumbled by 92.43% to $154688.0 in 2024, then plummeted by 61.72% to $59221.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Leases are $59221.0 (Q1 2025), $154688.0 (Q4 2024), and $264075.0 (Q3 2024).